This Guidance Note sets out an overview of the most common tax implications arising in Life Science licensing.

By reviewing the key components of the transaction at Heads of Terms, a number of potential issues can be ruled out, allowing focus to be applied to key aspects and the parties to agree terms when negotiations are more fluid.

This content is restricted to members. To view this content please register or login below to view this content.

Register to receive up-to-date information and advice on tax developments within your industry.